Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11295833rdf:typepubmed:Citationlld:pubmed
pubmed-article:11295833lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:11295833lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:11295833lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:11295833lifeskim:mentionsumls-concept:C0016904lld:lifeskim
pubmed-article:11295833lifeskim:mentionsumls-concept:C0042333lld:lifeskim
pubmed-article:11295833lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:11295833lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:11295833pubmed:issue4lld:pubmed
pubmed-article:11295833pubmed:dateCreated2001-4-11lld:pubmed
pubmed-article:11295833pubmed:abstractTextGABA (gamma-aminobutyric acid) is the principal inhibitory neurotransmitter in the brain. The human GABA(B) receptor (GABBR1) maps to the human leukocyte antigen (HLA) region of chromosome 6. Its function and location in a susceptibility region for schizophrenia, epilepsy, and dyslexia make GABBR1 a candidate gene for neurobehavioral disorders. We report the characterization of GABBR1 gene mutations in 100 chromosomes from a mixed American population. Eleven distinct mutations were found, including two previously reported missense mutations (A20V and G489S) and a previously reported silent 1977 T>C transition. Here, we report four novel silent substitutions (39C>T, 1473T>C, 1476T>C, 1545T>C) and four novel intron variants. These DNA variants may be useful in association and linkage studies of neurobehavioral disorders, and in pharmacogenetic studies of drugs targeting GABBR1.lld:pubmed
pubmed-article:11295833pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11295833pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11295833pubmed:languageenglld:pubmed
pubmed-article:11295833pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11295833pubmed:citationSubsetIMlld:pubmed
pubmed-article:11295833pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11295833pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11295833pubmed:statusMEDLINElld:pubmed
pubmed-article:11295833pubmed:monthAprlld:pubmed
pubmed-article:11295833pubmed:issn1098-1004lld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:MattsonR HRHlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:GoelV KVKlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:ChoiJJlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:PaullKKlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:GelernterJJlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:GruenJ RJRlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:GrigorenkoE...lld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:WoodF BFBlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:HisamaF MFMlld:pubmed
pubmed-article:11295833pubmed:authorpubmed-author:HuseinovicMMlld:pubmed
pubmed-article:11295833pubmed:copyrightInfoCopyright 2001 Wiley-Liss, Inc.lld:pubmed
pubmed-article:11295833pubmed:issnTypeElectroniclld:pubmed
pubmed-article:11295833pubmed:volume17lld:pubmed
pubmed-article:11295833pubmed:ownerNLMlld:pubmed
pubmed-article:11295833pubmed:authorsCompleteYlld:pubmed
pubmed-article:11295833pubmed:pagination349-50lld:pubmed
pubmed-article:11295833pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:meshHeadingpubmed-meshheading:11295833...lld:pubmed
pubmed-article:11295833pubmed:year2001lld:pubmed
pubmed-article:11295833pubmed:articleTitleHuman GABA(B) receptor 1 gene: eight novel sequence variants.lld:pubmed
pubmed-article:11295833pubmed:affiliationDepartment of Neurology, Yale University School of Medicine, New Haven, Connecticut 06520-8018, USA. fuki.hisama@yale.edulld:pubmed
pubmed-article:11295833pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11295833pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:11295833pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11295833lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11295833lld:pubmed